Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of the Administration of Tannin Specific Natural Extract, Chesnut and Quebracho Based, for Irritable Bowel Syndrome Diarrhea Predominant

NCT05207618 is registered in ClinicalTrials.gov with Hospital de Clinicas José de San Martín as lead sponsor.

NCT NCT05207618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05207618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of the Administration of Tannin Specific Natural Extract, Chesnut and Quebracho Based, for Irritable Bowel Syndrome Diarrhea Predominant
Lead sponsor
Hospital de Clinicas José de San Martín
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2021
Completion date
April 20, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, irritable bowel syndrome